Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Abroad (travel likely)RecruitingPHASE2

Conditions

VHL Pancreatic Neuroendocrine Tumors · Von Hippel-Lindau Disease · Neuroendocrine Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (For more information at the NIH Clinical Center contact National Cancer Institute Referral Office) · 888-624-1937

Study leads

Naris Nilubol, M.D.
Principal Investigator
National Cancer Institute (NCI)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Pheochromocytoma/Paraganglioma · Pancreatic Neuroendocrine Tumor · Von Hippel-Lindau Disease

IsraelRecruitingPHASE2

Los Angeles, United States · Chicago, United States

Familial Investigations of Childhood Cancer Predisposition

Acute Leukemia · Adenomatous Polyposis · Adrenocortical Carcinoma

Abroad (travel likely)Recruiting

Memphis, United States

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Neuroendocrine Neoplasm · Neuroendocrine Neoplasm of Gastrointestinal Tract · Neuroendocrine Neoplasm of Lung

Abroad (travel likely)Recruiting

Mexico City, Mexico · Mexico City, Mexico